Arcellx (ACLX) Share-based Compensation (2021 - 2025)

Arcellx's quarterly Share-based Compensation came in at $18.1 million in Q4 2025, up 14.6% year-on-year from $15.8 million in Q4 2024, and up 0.8% quarter-over-quarter from $17.9 million in Q3 2025.

Arcellx has reported Share-based Compensation for 5 years, with the latest figure at $18.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 14.6% year-over-year to $18.1 million; the trailing twelve-month figure through Dec 2025 stood at $77.9 million (up 27.51% YoY), and the FY2025 full-year result was $77.9 million, up 27.51% from the prior year.
  • Share-based Compensation for Q4 2025 stood at $18.1 million, up from $17.9 million in the prior quarter.
  • The five-year high for Share-based Compensation was $23.8 million in Q1 2025, with the low at $757000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $10.5 million, with a median of $10.5 million recorded in 2023.
  • Year-over-year, Share-based Compensation surged 491.94% in 2022 and climbed 14.6% in 2025.
  • Tracing ACLX's Share-based Compensation over 5 years: stood at $2.9 million in 2021, then surged by 99.52% to $5.8 million in 2022, then jumped by 83.33% to $10.6 million in 2023, then surged by 48.55% to $15.8 million in 2024, then rose by 14.6% to $18.1 million in 2025.
  • The last three Share-based Compensation figures came in at $18.1 million (Q4 2025), $17.9 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 892,057.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 305,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 70.15 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 18.07 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18.07 Mn
Dec 31, 2025 18.07 Mn
Sep 30, 2025 17.93 Mn
Sep 30, 2025 17.93 Mn
Jun 30, 2025 18.08 Mn
Jun 30, 2025 18.08 Mn
Mar 31, 2025 23.82 Mn
Mar 31, 2025 23.82 Mn
Dec 31, 2024 15.77 Mn
Dec 31, 2024 15.77 Mn
Sep 30, 2024 15.33 Mn
Sep 30, 2024 15.33 Mn
Jun 30, 2024 15.14 Mn
Jun 30, 2024 15.14 Mn
Mar 31, 2024 14.85 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 10.62 Mn
Dec 31, 2023 10.62 Mn
Sep 30, 2023 10.61 Mn
Sep 30, 2023 10.61 Mn
Jun 30, 2023 10.40 Mn
Jun 30, 2023 10.40 Mn
Mar 31, 2023 10.16 Mn
Mar 31, 2023 10.16 Mn
Dec 31, 2022 5.79 Mn
Dec 31, 2022 5.79 Mn
Sep 30, 2022 5.33 Mn
Sep 30, 2022 5.33 Mn
Jun 30, 2022 5.94 Mn
Jun 30, 2022 5.94 Mn
Mar 31, 2022 4.48 Mn
Mar 31, 2022 4.48 Mn
Dec 31, 2021 2.90 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 1.90 Mn
Sep 30, 2021 1.90 Mn
Jun 30, 2021 1.20 Mn
Jun 30, 2021 1.20 Mn
Mar 31, 2021 757,000.00
Mar 31, 2021 757,000.00